Organogenesis Holdings Inc (ORGO)
2.735
-0.12
(-4.04%)
USD |
NASDAQ |
May 17, 16:00
2.735
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Price to Book Value: 1.306 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.306 |
| May 16, 2024 | 1.359 |
| May 15, 2024 | 1.416 |
| May 14, 2024 | 1.357 |
| May 13, 2024 | 1.411 |
| May 10, 2024 | 1.445 |
| May 09, 2024 | 1.087 |
| May 08, 2024 | 1.102 |
| May 07, 2024 | 1.164 |
| May 06, 2024 | 1.140 |
| May 03, 2024 | 1.187 |
| May 02, 2024 | 1.187 |
| May 01, 2024 | 1.197 |
| April 30, 2024 | 1.120 |
| April 29, 2024 | 1.171 |
| April 26, 2024 | 1.120 |
| April 25, 2024 | 1.090 |
| April 24, 2024 | 1.421 |
| April 23, 2024 | 1.421 |
| April 22, 2024 | 1.416 |
| April 19, 2024 | 1.383 |
| April 18, 2024 | 1.364 |
| April 17, 2024 | 1.330 |
| April 16, 2024 | 1.364 |
| April 15, 2024 | 1.316 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.373 |
| April 11, 2024 | 1.430 |
| April 10, 2024 | 1.407 |
| April 09, 2024 | 1.392 |
| April 08, 2024 | 1.416 |
| April 05, 2024 | 1.349 |
| April 04, 2024 | 1.335 |
| April 03, 2024 | 1.320 |
| April 02, 2024 | 1.244 |
| April 01, 2024 | 1.335 |
| March 31, 2024 | |
| March 28, 2024 | 1.345 |
| March 27, 2024 | 1.307 |
| March 26, 2024 | 1.241 |
| March 25, 2024 | 1.241 |
| March 22, 2024 | 1.236 |
| March 21, 2024 | 1.260 |
| March 20, 2024 | 1.326 |
| March 19, 2024 | 1.302 |
| March 18, 2024 | 1.302 |
| March 15, 2024 | 1.350 |
| March 14, 2024 | 1.345 |
| March 13, 2024 | 1.421 |
| March 12, 2024 | 1.392 |
| March 11, 2024 | 1.411 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9332
Minimum
Mar 24 2023
59.99
Maximum
Nov 13 2019
9.164
Average
6.420
Median
Nov 05 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| PE Ratio | 76.83 |
| PS Ratio | 0.8352 |
| Price to Free Cash Flow | 53.42 |
| Price | 2.735 |
| Earnings Yield | 1.30% |
| Market Cap | 363.25M |
| Operating PE Ratio | 28.70 |
| Normalized PE Ratio | 76.83 |